Patents by Inventor Peter Herbert Proctor

Peter Herbert Proctor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220280493
    Abstract: The use of nitroxide and nitrone compounds for the treatment of acute, breakthrough, or “long-haul” respiratory coronavirus infections is claimed. Exemplars include Tempol and its reduced prodrug hydroxylamine form as well as PBN (N-Benzylidene-tert-butylamine N-oxide). Methods of administration include nasal insufflation, inhalation, topical to skin or mucosa, orally, intradermally, subcutaneously, by intravenus infusion, using suitable pharmacologically-active formulations.
    Type: Application
    Filed: February 23, 2022
    Publication date: September 8, 2022
    Inventor: Peter Herbert Proctor
  • Publication number: 20210386722
    Abstract: Nitrone, nitroso, and nitroxide drugs and their corresponding hydroxylamine reduction products are claimed for the acute and chronic treatment of Covid-19 and its variants.
    Type: Application
    Filed: July 9, 2021
    Publication date: December 16, 2021
    Inventor: Peter Herbert Proctor
  • Patent number: 10028943
    Abstract: Nitrone, nitroso, and nitroxide spintraps and spin labels and their reduction products are claimed for the treatment of dense breasts.
    Type: Grant
    Filed: July 5, 2015
    Date of Patent: July 24, 2018
    Inventors: Peter Herbert Proctor, Donna Marie RollingProctor
  • Publication number: 20170000776
    Abstract: Nitrone, nitroso, and nitroxide spintraps and spin labels and their reduction products are claimed for the treatment of dense breasts.
    Type: Application
    Filed: July 5, 2015
    Publication date: January 5, 2017
    Inventors: Peter Herbert Proctor, Donna Rolling-Proctor
  • Publication number: 20140275166
    Abstract: Spin-traps and spin labels and their reduction products are claimed for the treatment of peri- and post-menopausal syndrome.
    Type: Application
    Filed: March 5, 2014
    Publication date: September 18, 2014
    Inventor: Peter Herbert Proctor